NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026

NHS EnglandcontractFind a TenderRef ocds-h6vhtk-051c98Procurement Act 2023SME suitableclosed for bids
View buyer

Estimated value

£877.7m

goods

Awarded value

Suppliers

0

Lots

2

0 awarded

Published

17 Mar 2026

Deadline 17 Apr 2026

Total lots

2

Awarded

0

2 pending

Estimated total

£877.7m

Awarded total

Lot 1active

CM/PHR/25/5730/01 - Tranche B for NOFE and MAE

Estimated
£846.1m

Start

31 Aug 2026

End

31 Aug 2028

Estimated

£846.1m

CPV

33600000
No suppliers awarded yet for this lot.
Lot 2active

CM/PHR/25/5730/02 - Natalizumab for London & SOFE

Estimated
£31.5m

Start

31 Aug 2026

End

31 Aug 2027

Estimated

£31.5m

CPV

33600000
No suppliers awarded yet for this lot.